Javascript must be enabled to continue!
From Hai Yao, Yang Yao to Xi Yao: Sinification of Material Medical from the West
View through CrossRef
In ancient China, Daoist philosophers developed the concepts of qi (energy), Wu Xing (five elements), and yin (feminine, dark, negative) and yang (masculine, bright, positive) opposite forces between 200 and 600 BCE. Based on these philosophies, Zhen Jiu (acupuncture), Ben Cao (materia medica), and the practice of Qi Gong (energy optimization movements) evolved as the three interrelated therapeutic regimens of Chinese medicine (Note 1). Since the time of Zhang Qian, who discovered China’s western regions in the 1st century BCE, Hai Yao (the exotic elements of materia medica from the maritime Silk Road countries), had been transmitted from the ancient land and maritime routes of the Silk Road to China in the past two millennia (Note 2). Since the late 17th century, the English East India Company, later called the British East India Company, introduced Yang Yao (opium) to the Manchu Qing Empire to balance a growing trade deficit for tea export from China to the British Empire. After the First Opium War ended in 1842, enterprising expatriate chemists and druggists in the treaty ports imported Xi Yao (modern medicines from the Western world) for sale to the merchant navy and the local market. From the second half of the 19th century onwards, both Hai Yao and Xi Yao have become a fully integrated part of modern China’s armamentarium for the Chinese medicine and Western hospitals and retail pharmacy sectors. This paper articulates the journey of adoption of exotic elements of materia medica from the ancient land and sea routes of the Silk Road, including the western regions and the rest of the world in the past two millennia. Opium traders, ship surgeons, medical and pharmaceutical missionaries, enterprising traders, and policymakers together transformed Ben Cao into Xi Yao during the late Manchu Qing dynasty and the early Nationalist Era.
Title: From Hai Yao, Yang Yao to Xi Yao: Sinification of Material Medical from the West
Description:
In ancient China, Daoist philosophers developed the concepts of qi (energy), Wu Xing (five elements), and yin (feminine, dark, negative) and yang (masculine, bright, positive) opposite forces between 200 and 600 BCE.
Based on these philosophies, Zhen Jiu (acupuncture), Ben Cao (materia medica), and the practice of Qi Gong (energy optimization movements) evolved as the three interrelated therapeutic regimens of Chinese medicine (Note 1).
Since the time of Zhang Qian, who discovered China’s western regions in the 1st century BCE, Hai Yao (the exotic elements of materia medica from the maritime Silk Road countries), had been transmitted from the ancient land and maritime routes of the Silk Road to China in the past two millennia (Note 2).
Since the late 17th century, the English East India Company, later called the British East India Company, introduced Yang Yao (opium) to the Manchu Qing Empire to balance a growing trade deficit for tea export from China to the British Empire.
After the First Opium War ended in 1842, enterprising expatriate chemists and druggists in the treaty ports imported Xi Yao (modern medicines from the Western world) for sale to the merchant navy and the local market.
From the second half of the 19th century onwards, both Hai Yao and Xi Yao have become a fully integrated part of modern China’s armamentarium for the Chinese medicine and Western hospitals and retail pharmacy sectors.
This paper articulates the journey of adoption of exotic elements of materia medica from the ancient land and sea routes of the Silk Road, including the western regions and the rest of the world in the past two millennia.
Opium traders, ship surgeons, medical and pharmaceutical missionaries, enterprising traders, and policymakers together transformed Ben Cao into Xi Yao during the late Manchu Qing dynasty and the early Nationalist Era.
Related Results
FAKTOR-FAKTOR YANG MEMPENGARUHI MORTALITAS PADA PASIEN DENGAN FRAKTUR COSTA: Literature Review
FAKTOR-FAKTOR YANG MEMPENGARUHI MORTALITAS PADA PASIEN DENGAN FRAKTUR COSTA: Literature Review
FAKTOR-FAKTOR YANG MEMPENGARUHI MORTALITAS PADA PASIEN DENGAN FRAKTUR COSTA: Literature Review Anna Tri Wahyuni1), Masfuri2), Liya Arista3)1,2,3 Fakultas Ilmu Keperawatan Univers...
NILAI ESRTIKA MODIFIKASI VESPA ROSOK BONDOWOSO
NILAI ESRTIKA MODIFIKASI VESPA ROSOK BONDOWOSO
NILAI ESTETIKA VESPA MODIFIKASI KOMUNITAS VESPA BONDOWOSO Syarief Abdurahman Arrahim1, I Wayan Sudiarta2, I Gst Ngr. Sura Ardana31,2,3Program Studi Pendidikan Seni RupaFakultas Ba...
Epidemiological Features of Hospital Acquired Infection in a Tertiary Military Hospital
Epidemiological Features of Hospital Acquired Infection in a Tertiary Military Hospital
Background & objective: Hospital Acquired Infections (HAIs) are the major concern in developing countries commonly affecting the ill patients in hospital settings. This study w...
The role of HAI-1 in Urothelial Bladder Cancer: Tissue Expression, Ectodomain Shedding and Clinical Outcomes
The role of HAI-1 in Urothelial Bladder Cancer: Tissue Expression, Ectodomain Shedding and Clinical Outcomes
Hepatocyte growth factor activator inhibitor type-1 (HAI-1) plays pivotal roles in epithelial integrity and tumour biology. Although implicated in various malignancies, its express...
Krishi Prasankaran Main Udimita Vikas
Krishi Prasankaran Main Udimita Vikas
"Krshi hamaare desh mein jeevan ka aadhaar hai tatha praayah ise maatr aajeevika ke roop mein hee dekha jaata hai. Jabaki yah poshan ka bhee khajaana hai tatha paaristhitikee surak...
Conceptual design report of the Super Tau-Charm Facility: the accelerator
Conceptual design report of the Super Tau-Charm Facility: the accelerator
Abstract
Electron–positron colliders operating in the GeV center-of-mass range, or tau-charm energy region, have been proved to enable compet...
Serum hepatocyte growth factor activator inhibitor type I (HAI‐I) and type 2 (HAI‐2) in prostate cancer
Serum hepatocyte growth factor activator inhibitor type I (HAI‐I) and type 2 (HAI‐2) in prostate cancer
AbstractBACKGROUNDHepatocyte growth factor activator inhibitor type 1 (HAI‐1) and type 2 (HAI‐2) are Kunitz‐type serine protease inhibitors for hepatocyte growth factor activator (...

